Literature DB >> 20032391

Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer.

Ute Warnecke-Eberz1, Elfriede Bollschweiler, Uta Drebber, Ralf Metzger, Stephan E Baldus, Arnulf H Hölscher, Stefan Mönig.   

Abstract

BACKGROUND: PIM kinases are mediators of cytokine signalling pathways in hematopoietic cells and contribute to the progression of certain types of leukemia and solid tumor. Here the prognostic impact of proto-oncogene PIM-1 was analyzed in gastric carcinoma. PATIENTS AND METHODS: Cancer tissues of 117 patients with potentially curative (R0) resections for gastric cancer were immunohistochemically stained for PIM-1.
RESULTS: Cytoplasmic immunoreactivity for PIM-1 in tumor (46%) was higher (p=0.003) compared to that in gastric glands (16%) and foveolae (1%). PIM-1 immunoreactivity in gastric carcinoma correlated with tumor grading (p<0.05) and Laurén category (p<0.02). Overexpression of PIM-1 in gastric glands (p<0.001) was associated with formation of lymph node metastases (p=0.035) and survival (p=0.04). Multivariate analysis of PIM-1 expression in gastric glands confirmed its association with prognosis.
CONCLUSION: Up-regulation of PIM-1 oncogene might be a tumor marker for gastric cancer. The correlation of PIM-1 overexpression in gastric glands with formation of lymph node metastases and survival proposes a prognostic role in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032391

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

Review 1.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

2.  Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Authors:  Susann Herzog; Matthias Alexander Fink; Kerstin Weitmann; Claudius Friedel; Stefan Hadlich; Sönke Langner; Katharina Kindermann; Tobias Holm; Andreas Böhm; Eskil Eskilsson; Hrvoje Miletic; Markus Hildner; Michael Fritsch; Silke Vogelgesang; Christoph Havemann; Christoph Alexander Ritter; Henriette Elisabeth Meyer zu Schwabedissen; Bernhard Rauch; Wolfgang Hoffmann; Heyo Klaus Kroemer; Henry Schroeder; Sandra Bien-Möller
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

3.  Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair.

Authors:  Jui-Ling Hsu; Pui-Kei Leong; Yunn-Fang Ho; Lih-Ching Hsu; Pin-Hsuan Lu; Ching-Shih Chen; Jih-Hwa Guh
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

Review 4.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

5.  Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.

Authors:  Hong Kyeung Kim; Chae Won Kim; Mai-Tram Vo; Hyun Hee Lee; Ji Young Lee; Nal Ae Yoon; Chae Yeong Lee; Chang Hoon Moon; Young Joo Min; Jeong Woo Park; Wha Ja Cho
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

6.  Cytoplasmic Irradiation Induces Metabolic Shift in Human Small Airway Epithelial Cells via Activation of Pim-1 Kinase.

Authors:  Jinhua Wu; Qin Zhang; Yen-Ruh Wuu; Sirui Zou; Tom K Hei
Journal:  Radiat Res       Date:  2017-02-07       Impact factor: 2.841

7.  Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.

Authors:  Benedict Yan; Ee Xuan Yau; Sanjay Samanta; Chee Wee Ong; Kol Jia Yong; Lai Kuan Ng; Bhaskar Bhattacharya; Kiat Hon Lim; Richie Soong; Khay Guan Yeoh; Niantao Deng; Patrick Tan; Yulin Lam; Manuel Salto-Tellez
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

Review 8.  PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer.

Authors:  Sutapa Mahata; Pranab K Sahoo; Ranita Pal; Sinjini Sarkar; Tanuma Mistry; Sushmita Ghosh; Vilas D Nasare
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

9.  Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC).

Authors:  Yi Jin; Da-Yue Tong; Lu-Ying Tang; Jian-Ning Chen; Jing Zhou; Zhi-Ying Feng; Chun-Kui Shao
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

10.  Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach.

Authors:  Mingfeng Shao; Yiming Yuan; Kun Yu; Kai Lei; Guonian Zhu; Lijuan Chen; Mingli Xiang
Journal:  Mol Divers       Date:  2014-02-12       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.